Preparation method of glufosinate-ammonium or derivative thereof

By simplifying the preparation method of glufosinate, the use of easily obtained phosphorus-containing reagents to react in the presence of water and acid or alkali, the problems of complex processes and high toxicity and high cost of reagents in the prior art are solved, and high efficiency is achieved suitable for industrial production Preparation and optical purity production of glufosinate.

CN119019447APending Publication Date: 2024-11-26LIER CHEM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410652325.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-23
Filing Date
2024-05-23
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing preparation methods for glufosinate ammonium are complex and are not suitable for large-scale production, and use highly toxic and expensive reagents.

Method used

A method for preparing glufosinate or derivatives thereof is provided, using easily obtained phosphorus-containing reagents, simplifying the process steps by reacting in the presence of water and acid or base, and including the removal step of amino protecting groups, Suitable for industrial scale production.

Benefits of technology

This method significantly shortens the preparation process steps, has excellent reaction yield, is cheap in the reagents used, is suitable for large-scale production, and effectively maintains the optical purity of L-glufosinate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019447A_ABST
    Figure CN119019447A_ABST
Patent Text Reader

Abstract

The present disclosure relates to a process for the preparation of glufosinate-ammonium of formula (I) or a derivative thereof, comprising reacting a compound of formula (II) or a salt, enantiomer or a mixture of all proportions of enantiomers thereof with a phosphorus-containing reagent; and then reacting in the presence of water and acid or alkali to obtain glufosinate-ammonium (I) or salts thereof, enantiomers or a mixture of enantiomers in all proportions regardless of whether the intermediate is separated or not. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to a method for preparing glufosinate-ammonium or a derivative thereof. Background Art

[0002] Glufosinate is a highly effective, broad-spectrum, low-toxic, non-selective (killing) organophosphorus herbicide developed by Hoechst in the 1980s with partial systemic action. It can be used to control annual and perennial dicotyledonous and grass weeds. Glufosinate has two enantiomers, L-type and D-type. The herbicidal activity of L-type glufosinate is twice that of racemic DL-type glufosinate.

[0003] Existing methods for preparing glufosinate-ammonium have many defects (eg, complex processes, not suitable for large-scale production, use of highly toxic and / or expensive reagents, etc.). Summary of the invention

[0004] The present disclosure provides a method for preparing glufosinate-ammonium or its derivatives. The raw materials used in the method are easy to obtain, and the process operation is suitable for industrial-scale production.

[0005] In some embodiments, the present disclosure provides a method for preparing glufosinate-ammonium or its salt, enantiomer or mixture of enantiomers in all proportions of formula (I), characterized in that the method comprises the following steps:

[0006]

[0007] a) reacting a compound of formula (II) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios with a phosphorus-containing reagent (preferably a compound of formula (III), formula (III)-1, formula (III)-2, formula (III)-3 and / or formula (III)-4),

[0008]

[0009] b) reacting in the presence of water and an acid or base to obtain glufosinate (I) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios, regardless of whether the intermediate is isolated or not;

[0010] When PG is an amino protecting group, the step of removing the amino protecting group may also be included;

[0011] in:

[0012] X is -OR c 、-SR c Or -SeR c ;

[0013] Y is -OH, -OR1, -NH2, -NHR2 or -N(R2)(R3);

[0014] PG is hydrogen or an amino protecting group, and the amino protecting group is preferably -C(=O)R4, -C(=O)OR4 or -S(=O)2R4;

[0015] R1, R2 and R3 are each independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl or -Si(R5)(R6)(R7);

[0016] R4 is selected from C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0017] R5, R6 and R7 are each independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14-membered heteroaryl or 3-10-membered heterocyclic group;

[0018] R, R" and R"' are each independently selected from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b 、-Si(R5)(R6)(R7),

[0019] R' is independently selected at each occurrence from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b and -Si(R5)(R6)(R7);

[0020] R a and R b Each occurrence is independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclic group; or when R a and R b When connected to the same nitrogen atom, R a , R b Optionally, together with the nitrogen atom, they form a 3-10 membered heterocyclic ring;

[0021] R c Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R d 、-S(=O)R d ,-PH(=O)R d and -P(OH)(=O)R d ;

[0022] Hal is independently at each occurrence a halogen selected from fluorine, chlorine, bromine and iodine;

[0023] R d Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0024] The above alkylene, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl and heterocyclic groups are each optionally substituted by one or more substituents independently selected from the following: halogen, -OH, =O, -O-(C1-C6 alkyl), -C(=O)-(C1-C6 alkyl), -C(=O)OH, -C(=O)O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0025] n is an integer selected from 1 to 6, preferably 1, 2 or 3;

[0026] Chiral carbon atoms are marked with *.

[0027] In some embodiments, the present disclosure provides a method for preparing a compound of formula (I)-1 or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios, characterized in that the method comprises the following steps:

[0028]

[0029] a) reacting a compound of formula (II) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios with a phosphorus-containing reagent (preferably a compound of formula (III), formula (III)-1, formula (III)-2, formula (III)-3 and / or formula (III)-4),

[0030]

[0031] b-1) reacting in the presence of R8OH to obtain a compound of formula (I)-1 or a salt thereof, an enantiomer or a mixture of enantiomers in all proportions, regardless of whether the intermediate is isolated or not;

[0032] When PG is an amino protecting group, the step of removing the amino protecting group may also be included;

[0033] in:

[0034] X is -OR c 、-SR c Or -SeR c ;

[0035] Y is -OH, -OR1, -NH2, -NHR2 or -N(R2)(R3);

[0036] PG is hydrogen or an amino protecting group, and the amino protecting group is preferably -C(=O)R4, -C(=O)OR4 or -S(=O)2R4;

[0037] R1, R2 and R3 are each independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl or -Si(R5)(R6)(R7);

[0038] R4 is selected from C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0039] R5, R6 and R7 are each independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14-membered heteroaryl or 3-10-membered heterocyclic group;

[0040] R, R" and R"' are each independently selected from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b 、-Si(R5)(R6)(R7),

[0041] R' is independently selected at each occurrence from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b and -Si(R5)(R6)(R7);

[0042] R a and R b Each occurrence is independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclic group; or when R a and R b When connected to the same nitrogen atom, R a , R b Optionally, together with the nitrogen atom, they form a 3-10 membered heterocyclic ring;

[0043] R c Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R d 、-S(=O)R d ,-PH(=O)R d and -P(OH)(=O)R d ;

[0044] Hal is independently at each occurrence a halogen selected from fluorine, chlorine, bromine and iodine;

[0045] R d Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0046] R8 is H, C1-C6 alkyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl or 3-10 membered heterocyclyl; preferably, R8 is H or C1-C6 alkyl; more preferably, R8 is H, methyl or ethyl;

[0047] The above alkylene, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl and heterocyclic groups are each optionally substituted by one or more substituents independently selected from the following: halogen, -OH, =O, -O-(C1-C6 alkyl), -C(=O)-(C1-C6 alkyl), -C(=O)OH, -C(=O)O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl;

[0048] n is an integer selected from 1 to 6, preferably 1, 2 or 3;

[0049] Chiral carbon atoms are marked with *.

[0050] In some embodiments, the compound of formula (II) in step a) above is enantiomerically pure, and the obtained glufosinate-ammonium or salt thereof or compound of formula (I)-1 or salt thereof is also enantiomerically pure.

[0051] In some embodiments, the enantiomeric ratio of glufosinate ammonium or its salt or the compound of formula (I)-1 or its salt prepared by the above method is 50.5:49.5 to 99.5:0.5 for (L):(D)-enantiomer or (D):(L)-enantiomer.

[0052] In some embodiments, R is not added in step a). e OH;

[0053] R e Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R f 、-S(=O)R f 、-S(=O)2R f ,-PH(=O)R f and -P(OH)(=O)R f ;

[0054] R f Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl.

[0055] In some embodiments, no H2O is added in step a).

[0056] In some embodiments, R c Each occurrence is independently selected from hydrogen, C1-C6 alkyl, -C(=O)R d and -PH(=O)R d , and R d is C1-C6 alkyl or C 6-10 Aryl.

[0057] In some embodiments, X is -OH or -OAc.

[0058] In some embodiments, X is -OH, that is, the compound of formula (II) is a compound of formula (II)-1:

[0059]

[0060] In some embodiments, R1, R2 and R3 are each independently C1-C6 alkyl, C 6-10 Aryl or C 6-12 Aralkyl.

[0061] In some embodiments, R1, R2 and R3 are each independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, phenyl, benzyl, phenethyl, phenylpropyl, methylphenyl, ethylphenyl, propylphenyl or naphthyl.

[0062] In some embodiments, Y is -NHCH2CH2CH2CH3, -N(CH3)2, -OCH3, -OCH2CH3, -OCH2CH2CH3, -OCH(CH3)2, -OCH2CH2CH2CH3, -OCH2CH(CH3)2, or -OBn.

[0063] In some embodiments, Y is -OR1, and R1 is preferably methyl, ethyl, n-propyl, isopropyl or n-butyl.

[0064] In some embodiments, PG is hydrogen, -C(=O)CH3, -C(=O)Ph, -C(=O)OC2H5, -C(=O)OC(CH3)3 or

[0065] In some embodiments, PG is hydrogen.

[0066] In some embodiments, a compound of formula (II) or a salt, an enantiomer, or a mixture of enantiomers in all ratios thereof is reacted with a compound of formula (III).

[0067] In some embodiments, R and R' are each independently H, halogen, -OR a or -NR a R b , R a and R b Each occurrence is independently hydrogen, C1-C6 alkyl, C 3-10 Cycloalkyl, C 6-10 Aryl or C 6-12 Aralkyl; preferably, R a and R b Each occurrence is independently hydrogen or C1-C6 alkyl.

[0068] In some embodiments, R and R' are each independently H, Cl, -OH, -OEt, -NH2, or -N(CH3)2.

[0069] In some embodiments, R and R' are not both -OR a .

[0070] In some embodiments, the compound of formula (III) is

[0071]

[0072] Among them, Hal 1 and Hal 2 Each is independently a halogen selected from fluorine, chlorine, bromine and iodine.

[0073] In some embodiments, the compound of formula (III) is

[0074]

[0075] Among them, Hal 1 is a halogen selected from fluorine, chlorine, bromine and iodine;

[0076] R a As defined above.

[0077] In some embodiments, the compound of formula (III) is

[0078]

[0079] Where R a As defined above.

[0080] In some embodiments, the compound of formula (III) is

[0081]

[0082] Among them, Hal 1 is a halogen selected from fluorine, chlorine, bromine and iodine;

[0083] R a and R b As defined above;

[0084] Preferably, the R a and R b Each is independently selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, phenyl, benzyl, phenethyl, phenylpropyl, methylphenyl, ethylphenyl, propylphenyl or naphthyl.

[0085] In some embodiments, the compound of formula (III) is

[0086]

[0087] Where R a and R b As defined above;

[0088] Preferably, the R a and R b Each is independently selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, phenyl, benzyl, phenethyl, phenylpropyl, methylphenyl, ethylphenyl, propylphenyl or naphthyl.

[0089] In some embodiments, the compound of formula (III)-1 is

[0090]

[0091] Where R is halogen, -OR a or -NR a R b ;

[0092] Preferably, R is -Cl, -OH, -OCH2CH3, -NH2 or -N(CH3)2.

[0093] In some embodiments, the compound of formula (III)-2 is

[0094]

[0095] Where R is halogen, -OR a or -NR a R b ; Preferably, R is -Cl, -OH, -OCH2CH3, -NH2 or -N(CH3)2;

[0096] R" is H or C 1-6 Alkyl (preferably methyl).

[0097] In some embodiments, the compound of formula (III)-4 is

[0098]

[0099] Where R is halogen, -OR a or -NR a R b ;

[0100] Preferably, R is -Cl, -OH, -OCH2CH3, -NH2 or -N(CH3)2.

[0101] In some embodiments, the compound of formula (III) is selected from:

[0102]

[0103] In some embodiments, the compound of formula (III) is selected from:

[0104]

[0105] When R is -OR a When the compound of formula (III) is present in the following tautomeric forms:

[0106]

[0107] In some embodiments, the molar ratio of the compound of formula (II) to the phosphorus-containing reagent is less than 2:1, preferably less than 1.5:1, and more preferably about 1:1.

[0108] In some embodiments, the compound of formula (II) can participate in the reaction in the form of a cyclic or chain polymer of the following structure:

[0109]

[0110] in

[0111] m is an integer from 0 to 10;

[0112] The remaining groups are as defined above;

[0113] In this case, the molar ratio of the monomers of the polymer to the phosphorus-containing reagent is less than 2:1, preferably less than 1.5:1, more preferably not higher than 1:1.

[0114] In some embodiments, in step a), the reaction temperature is -50 to 200°C, preferably -20 to 150°C, -20 to 140°C, -20 to 100°C, -20 to 50°C, -20 to 30°C, 20 to 100°C or 0 to 100°C.

[0115] In some embodiments, in step a), the reaction is first carried out at a first reaction temperature, and then the temperature is raised to a second reaction temperature to continue the reaction;

[0116] Wherein, the first reaction temperature is -50 to 100°C, preferably -20 to 30°C; the second reaction temperature is 30-200°C, preferably 90-150°C.

[0117] In some embodiments, when at the second reaction temperature, the reaction is carried out in the presence of a catalyst, and the catalyst is preferably an organic iodide, an inorganic iodide, an organic bromide, an inorganic bromide, an organic chloride or an inorganic chloride; preferably elemental iodine, TBAI (tetrabutylammonium iodide), TMSI (trimethylsilyl iodide), NCS (N-chlorosuccinimide), sodium iodide, potassium iodide or AlCl3.

[0118] In some embodiments, the molar ratio of the catalyst to the compound of formula (III) is (0.01-1):1, preferably (0.01-0.5):1.

[0119] In some embodiments, no halogenated acid (eg, hydrogen chloride gas) is added in step a).

[0120] In some embodiments, step a) is performed in the presence of a base, which is an inorganic base or an organic base;

[0121] The inorganic base is preferably ammonia, an alkali metal oxide, an alkaline earth metal oxide, an alkali metal carbonate, an alkaline earth metal carbonate, an alkali metal bicarbonate or an alkaline earth metal bicarbonate; for example, ammonia, potassium bicarbonate, sodium bicarbonate, lithium carbonate, potassium carbonate, sodium carbonate, cesium carbonate, calcium carbonate, magnesium carbonate, calcium oxide and magnesium oxide;

[0122] The organic base is preferably diethylamine, triethylamine, N,N-dimethylaniline, piperidine or pyridine, wherein the triethylamine, N,N-dimethylaniline, piperidine and pyridine are optionally substituted by 1 to 3 substituents selected from halogen, -OH, -O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C 3-10 Cycloalkyl and C 6-10 Aryl.

[0123] In some embodiments, in the above step a), the molar ratio of the base to the compound of formula (III) is (1-10):1, for example (1-5):1.

[0124] In some embodiments, step a) is performed in the absence of a solvent or in an inert solvent.

[0125] In some embodiments, the inert solvent is selected from any one or more of benzene solvents, nitrile solvents, amide solvents, hydrocarbon solvents, halogenated hydrocarbon solvents, sulfone or sulfoxide solvents, ether solvents or ester solvents; preferably, the inert solvent is selected from any one or more of benzene solvents, amide solvents, halogenated hydrocarbon solvents, ether solvents or ester solvents.

[0126] In some embodiments, the inert solvent is selected from any one or more of chlorobenzene, toluene, xylene, trimethylbenzene, acetonitrile, 1,4-dioxane, 1,2-dichloroethane, dimethyl sulfoxide, N-methylpyrrolidone, N,N-dimethylformamide, petroleum ether, n-heptane, tetrahydrofuran, methyltetrahydrofuran, benzene, toluene, ethyl acetate, and butyl acetate.

[0127] In some embodiments, in the above step b), an inorganic acid or an organic acid is added.

[0128] In some embodiments, the inorganic acid is hydrochloric acid or sulfuric acid.

[0129] In some embodiments, in the above step b), the base is an inorganic base or an organic base.

[0130] In some embodiments, the base is an alkali metal hydroxide, an alkaline earth metal hydroxide, an alkali metal carbonate, an alkaline earth metal carbonate, an alkali metal bicarbonate, or an alkaline earth metal bicarbonate.

[0131] In some embodiments, the base is NaOH, KOH, or Ba(OH)2.

[0132] In some embodiments, in the above step b), the reaction temperature is 20-150°C.

[0133] In some embodiments, in the above step b-1), the reaction temperature is 0°C to 100°C, for example, at a temperature of 0°C to 80°C, 0°C to 60°C, 0°C to 40°C, 0°C to 30°C, 0°C to 20°C, 30°C to 80°C or 30°C to 60°C.

[0134] The method of the present invention is particularly suitable for the preparation of glufosinate ammonium, greatly shortens the steps of the existing preparation process, and has an excellent reaction yield. The phosphorus-containing reagent used in the method disclosed in the present invention is easy to obtain and low in cost, which makes the method disclosed in the present invention suitable for large-scale industrial production.

[0135] In addition, in the preparation of L-phosphinothricin ammonium, the product can effectively maintain the ee value of the raw material. For example, when using an enantiomerically pure (e.g., enantiomeric excess (%ee) greater than 90%, preferably greater than 95%) raw material, the enantiomeric excess (%ee) of the prepared L-phosphinothricin ammonium is, for example, greater than 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%.

[0136] definition

[0137] Unless otherwise defined, the meanings of all technical terms and scientific terms used herein are intended to be the same as those generally understood by those skilled in the art. Reference to the technology used herein is intended to refer to the technology generally understood in the art, including those changes in technology that are obvious to those skilled in the art or replacement of equivalent technology. Although it is believed that the following terms are well understood by those skilled in the art, the following definitions are still set forth to better explain the present invention.

[0138] As used herein, the terms "comprises," "comprising," "having," "containing," or "involving," and other variations thereof herein, are inclusive or open-ended and do not exclude additional unrecited elements or method steps.

[0139] The term "amino protecting group" refers to a group that can be attached to the nitrogen atom on the amino group to protect the amino group from participating in the reaction and which can be easily removed in the subsequent reaction. Suitable amino protecting groups include, but are not limited to, the following protecting groups:

[0140] Formula -C(=O)OR x A carbamate group, wherein R x For example, methyl, ethyl, tert-butyl, benzyl, phenethyl, CH2=CH-CH2-, etc.; formula -C(=O)R y An amide group, wherein R y For example, methyl, ethyl, phenyl, trifluoromethyl, etc.; formula -S(=O)2-R z N-sulfonyl derivatives-groups, wherein R z For example, tolyl, phenyl, trifluoromethyl, 2,2,5,7,8-pentamethylchroman-6-yl, 2,3,6-trimethyl-4-methoxybenzene, and the like.

[0141] The term "alkyl" refers to a saturated aliphatic hydrocarbon group, including straight and branched groups of 1 to 18 carbon atoms. Preferably, the alkyl group contains 1 to 6 carbon atoms (i.e., C1-C6 alkyl), such as methyl, ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl, amyl, etc. The alkyl group may be substituted or unsubstituted, and when substituted, the substituent may be halogen, nitro, sulfonyl, etheroxy, etherthio, ester, thioester, or cyano.

[0142] C1-C4 alkyl is a straight or branched, saturated hydrocarbon chain containing 1 to 4 carbon atoms. It can be a methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl or tert-butyl group.

[0143] As used herein, the term "alkenyl" means a linear or branched monovalent hydrocarbon radical containing one or more double bonds and having 2 to 6 carbon atoms ("C 2-6The alkenyl group is, for example, vinyl, 1-propenyl, 2-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-methyl-2-propenyl and 4-methyl-3-pentenyl. When the compounds of the present invention contain an alkenyl group, the compounds may be present in the pure E (entgegen) form, the pure Z (zusammen) form or any mixture thereof.

[0144] As used herein, the term "alkynyl" denotes a monovalent hydrocarbon group containing one or more triple bonds, preferably having 2, 3, 4, 5 or 6 carbon atoms, such as ethynyl or propynyl.

[0145] As used herein, the term "cycloalkyl" refers to a saturated monocyclic or polycyclic (such as bicyclic) hydrocarbon ring (e.g., a monocyclic ring such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, or a bicyclic ring, including a spirocyclic, fused or bridged system (such as bicyclo[1.1.1]pentyl, bicyclo[2.2.1]heptyl, bicyclo[3.2.1]octyl or bicyclo[5.2.0]nonyl, decalinyl, etc.), which is optionally substituted with 1 or more (such as 1 to 3) suitable substituents. The cycloalkyl group has 3 to 15 carbon atoms. For example, the term "C 3-10 "Cycloalkyl" refers to a saturated monocyclic or polycyclic (such as bicyclic) hydrocarbon ring of 3 to 10 ring carbon atoms (for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl), which is optionally substituted by 1 or more (such as 1 to 3) suitable substituents, for example methyl substituted cyclopropyl.

[0146] As used herein, the term "heterocyclyl" refers to a saturated or unsaturated monovalent monocyclic or bicyclic group having 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms and one or more (e.g., one, two, three or four) selected from C(=O), O, S, S(=O), S(=O)2 and NR w A heteroatom-containing group, wherein R w Represents a hydrogen atom or C 1-6 Alkyl or halo-C 1-6alkyl; the heterocyclyl may be attached to the rest of the molecule via any of the carbon atoms or the nitrogen atom, if present. In particular, a 3-10 membered heterocyclyl is a group having 3-10 carbon atoms and heteroatoms in the ring, such as, but not limited to, an oxirane, an aziridine, an azetidinyl, an oxetanyl, a tetrahydrofuranyl, a dioxolyl, a pyrrolidinyl, a pyrrolidonyl, an imidazolidinyl, a pyrazolidinyl, a pyrrolinyl, a tetrahydropyranyl, a piperidinyl, a morpholinyl, a dithianyl, a thiomorpholinyl, a piperazinyl or a trithianyl.

[0147] As used herein, the term "aryl" refers to an all-carbon monocyclic or fused-ring polycyclic aromatic group having a conjugated π electron system. 6-10 "Aryl" means an aromatic group containing 6 to 10 carbon atoms, such as phenyl or naphthyl. The aryl group is optionally substituted by 1 or more (such as 1 to 3) suitable substituents (e.g., halogen, -OH, -CN, -NO2, C 1-6 alkyl, etc.) substituted.

[0148] As used herein, the term "aralkyl" preferably refers to an alkyl substituted with an aryl group, wherein the aryl group and the alkyl group are as defined herein. Typically, the aryl group may have 6-10 carbon atoms, and the alkyl group may have 1-6 carbon atoms. Exemplary aralkyl groups include, but are not limited to, benzyl, phenylethyl, phenylpropyl, phenylbutyl.

[0149] As used herein, the term "heteroaryl" refers to a monovalent monocyclic, bicyclic or tricyclic aromatic ring system having 5, 6, 8, 9, 10, 11, 12, 13 or 14 ring atoms, in particular 1 or 2 or 3 or 4 or 5 or 6 or 9 or 10 carbon atoms, and which contains at least one heteroatom which may be identical or different (the heteroatom being, for example, oxygen, nitrogen or sulfur) and, in each case, may additionally be benzo-fused. In particular, heteroaryl is selected from thienyl, furanyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl and the like, and benzo derivatives thereof; or pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl and the like, and benzo derivatives thereof.

[0150] As used herein, the term "substitution" refers to the replacement of one or more (e.g., one, two, three, or four) hydrogens on the designated atom with a selection from the indicated group, provided that the normal valence of the designated atom in the present context is not exceeded and the substitution forms a stable compound. Combinations of substituents and / or variables are permitted only if such combinations form stable compounds.

[0151] As used herein, "a mixture of enantiomers in all ratios" has the same meaning as "a mixture of enantiomers in any ratio". DETAILED DESCRIPTION

[0152] Embodiment 1:

[0153]

[0154] Step a).

[0155] Place L-homoserine methyl ester hydrochloride (10mmol, 1.69g, 1eq) in a sealed tube, evacuate the air, add 1,2-dichloroethane (DCE) (20mL) and pyridine (30mmol, 2.37g, 3eq) under N2 atmosphere, add MDP (10mmol, 1.17g, 1eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, and heat to 100℃ and react overnight.

[0156] Step b).

[0157] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 80% and an ee value of 90%.

[0158] Embodiment 2:

[0159]

[0160] Step a).

[0161] Place L-homoserine methyl ester hydrochloride (10mmol, 1.69g, 1eq) in a sealed tube, evacuate the air, add DCE (20mL) and pyridine (30mmol, 2.37g, 3eq) under N2 atmosphere, add MDP (10mmol, 1.17g, 1eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, add TBAI (1mmol, 0.370g, 0.1eq), heat to 100℃ and react overnight.

[0162] Step b).

[0163] The solvent of the reaction mixture obtained in step a) was dried by rotary evaporation, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 81% and an ee value of 92%.

[0164] Embodiment 3:

[0165]

[0166] Step a).

[0167] Place L-homoserine methyl ester hydrochloride (10mmol, 1.69g, 1eq) in a sealed tube, evacuate the air, add DCE (20mL) and pyridine (30mmol, 2.37g, 3eq) under N2 atmosphere, add MDP (10mmol, 1.17g, 1eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, add I2 (1mmol, 0.254g, 0.1eq), heat to 100℃ and react overnight.

[0168] Step b).

[0169] The solvent of the reaction mixture obtained in step a) was dried by rotary evaporation, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 80% and an ee value of 92%.

[0170] Embodiment 4:

[0171]

[0172] Step a).

[0173] Place L-homoserine butyl ester (10mmol, 1.76g, 1eq) in a sealed tube, evacuate the air, add 1,4-dioxane (20mL), acetonitrile (5mL) and pyridine (20mmol, 1.58g, 2eq) under N2 atmosphere, add MDP (10mmol, 1.17g, 1eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material reacts completely, and heat to 100℃ and react overnight.

[0174] Step b).

[0175] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 85% and an ee value of 93%.

[0176] Embodiment 5:

[0177]

[0178] Step a).

[0179] L-homoserine butyl ester (10mmol, 1.76g, 1eq) was placed in a sealed tube, ventilated, and DCE (20mL) and triethylamine (30mmol, 3.03g, 3eq) were added under N2 atmosphere, and MDP (15mmol, 1.76g, 1.5eq) was added under ice bath, and stirred at room temperature for half an hour. The reaction of the raw materials was complete after mass spectrometry detection, and the reaction was heated to 100℃ overnight.

[0180] Step b).

[0181] The solvent of the reaction mixture obtained in step a) was dried by rotary evaporation, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 91% and an ee value of 95%.

[0182] Embodiment 6:

[0183]

[0184] Step a).

[0185] Place L-homoserine butyl ester (10mmol, 1.76g, 1eq) in a sealed tube, evacuate the air, add chlorobenzene (20mL) and triethylamine (30mmol, 3.03g, 3eq) under N2 atmosphere, add MDP (15mmol, 1.76g, 1.5eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, and heat to 100℃ and react overnight.

[0186] Step b).

[0187] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 90% and an ee value of 95%.

[0188] Embodiment 7:

[0189]

[0190] Step a).

[0191] Place L-homoserine butyl ester (10mmol, 1.76g, 1eq) in a sealed tube, evacuate the air, add chlorobenzene (20mL) and triethylamine (30mmol, 3.03g, 3eq) under N2 atmosphere, add MDP (15mmol, 1.76g, 1.5eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, add TMSI (1mmol, 0.2g, 0.1eq), heat to 100℃ and react overnight.

[0192] Step b).

[0193] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 92% and an ee value of 96%.

[0194] Embodiment 8:

[0195]

[0196] Step a).

[0197] Place L-homoserine butyl ester (10mmol, 1.76g, 1eq) in a sealed tube, evacuate the air, add chlorobenzene (20mL) and triethylamine (30mmol, 3.03g, 3eq) under N2 atmosphere, add MDP (15mmol, 1.76g, 1.5eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, add NCS (1mmol, 0.13g, 0.1eq), heat to 100℃ and react overnight.

[0198] Step b).

[0199] The solvent of the reaction mixture obtained in step a) was dried by rotary evaporation, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 85% and an ee value of 92%.

[0200] Embodiment 9:

[0201]

[0202] Step a).

[0203] L-homoserine butyl ester (10mmol, 1.76g, 1eq) was placed in a sealed tube, ventilated, and chlorobenzene (20mL) and triethylamine (30mmol, 3.03g, 3eq) were added under N2 atmosphere, and MDP (15mmol, 1.76g, 1.5eq) was added under ice bath, and stirred at room temperature for half an hour. The reaction of the raw materials was complete after mass spectrometry detection, and NaI (1mmol, 0.15g, 0.1eq) was added, and the mixture was heated to 100°C and reacted overnight.

[0204] Step b).

[0205] The solvent of the reaction mixture obtained in step a) was dried by rotary evaporation, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 88% and an ee value of 93%.

[0206] Embodiment 10:

[0207]

[0208] Step a).

[0209] Place L-homoserine butyl ester (10mmol, 1.76g, 1eq) in a sealed tube, evacuate the air, add chlorobenzene (20mL) and triethylamine (30mmol, 3.03g, 3eq) under N2 atmosphere, add MDP (15mmol, 1.76g, 1.5eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, add AlCl3 (10mmol, 1.33g, 1eq), heat to 100℃ and react overnight.

[0210] Step b).

[0211] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 86% and an ee value of 92%.

[0212] Embodiment 11:

[0213]

[0214] Step a).

[0215] Place L-homoserine isopropyl ester hydrochloride (10 mmol, 1.97 g, 1 eq) in a sealed tube, evacuate the air, add DCE (20 mL) and triethylamine (40 mmol, 4.04 g, 4 eq) under N2 atmosphere, add MDP (15 mmol, 1.76 g, 1.5 eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, and heat to 100°C and react overnight.

[0216] Step b).

[0217] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 85% and an ee value of 93%.

[0218] Embodiment 12:

[0219]

[0220] Step a).

[0221] Place L-homoserine isopropyl ester (10 mmol, 1.62 g, 1 eq) in a sealed tube, evacuate the air, add DCE (20 mL), acetonitrile (5 mL) and triethylamine (40 mmol, 4.04 g, 4 eq) under N2 atmosphere, add MDP (15 mmol, 1.76 g, 1.5 eq) under ice bath, warm to room temperature and stir for half an hour. Mass spectrometry shows that the raw material has reacted completely, and heat to 100 °C and react overnight.

[0222] Step b).

[0223] The solvent of the reaction mixture obtained in step a) was spin-dried, 36% hydrochloric acid (100 mmol, 10 g, 10 eq) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 89% and an ee value of 93%.

[0224] Example 13

[0225]

[0226] Preparation of phosphorus-containing reagents

[0227] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (22 mmol, 1.63 g, 2.2 eq) was added dropwise, and the mixture was filtered to obtain compound 2, which was directly used in step a).

[0228] Step a).

[0229] L-homoserine butyl ester hydrochloride (10mmol, 2.11g, 1eq) was placed in a sealed tube, ventilated, and chlorobenzene (20mL) was added under N2 atmosphere, and the prepared compound 2 and triethylamine (21mmol, 2.12g, 2.1eq) were added under ice bath, and stirred for 1 hour in ice bath. The reaction of the raw materials was complete when detected by mass spectrometry, and the temperature was raised to 120℃ and heated for 8 hours.

[0230] Step b).

[0231] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate-ammonium with a yield of 88% and an ee value of 93%.

[0232] Embodiment 14

[0233]

[0234] Preparation of phosphorus-containing reagents

[0235] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (22 mmol, 1.63 g, 2.2 eq) was added dropwise, and the mixture was filtered to obtain compound 2, which was directly used in step a).

[0236] Step a).

[0237] L-homoserine butyl ester hydrochloride (10mmol, 2.11g, 1eq) was placed in a sealed tube, ventilated, and chlorobenzene (20mL) was added under N2 atmosphere. The prepared compound 2 and triethylamine (21mmol, 2.12g, 2.1eq) were added under ice bath, and stirred for 1 hour under ice bath. The reaction of the raw materials was complete after mass spectrometry detection, and NaI (1mmol, 0.15g, 0.1eq) was added, and the temperature was raised to 120℃ and heated for 8 hours.

[0238] Step b).

[0239] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate with a yield of 88% and an ee value of 94%.

[0240] Embodiment 15

[0241]

[0242] Preparation of phosphorus-containing reagents

[0243] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (22 mmol, 1.63 g, 2.2 eq) was added dropwise, and the mixture was filtered to obtain compound 2, which was directly used in step a).

[0244] Step a).

[0245] L-homoserine butyl ester hydrochloride (10mmol, 2.11g, 1eq) was placed in a sealed tube, ventilated, and chlorobenzene (20mL) was added under N2 atmosphere. The prepared compound 2 and triethylamine (21mmol, 2.12g, 2.1eq) were added under ice bath, and stirred for 1 hour under ice bath. The reaction of the raw materials was complete after mass spectrometry detection, and I2 (1mmol, 0.25g, 0.1eq) was added, and the temperature was raised to 120°C and heated for 8 hours.

[0246] Step b).

[0247] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate with a yield of 90% and an ee value of 95%.

[0248] Example 16

[0249]

[0250] Preparation of phosphorus-containing reagents

[0251] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (42 mmol, 3.12 g, 4.2 eq) was added dropwise, and the mixture was filtered to obtain compound 5, which was directly used in step a).

[0252] Step a).

[0253] L-homoserine butyl ester hydrochloride (10 mmol, 2.11 g, 1 eq) was placed in a sealed tube, vented, and chlorobenzene (20 mL) and the prepared compound 5 were added under N2 atmosphere, and heated at 120°C for 8 hours.

[0254] Step b).

[0255] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 79% and an ee value of 85%.

[0256] Embodiment 17

[0257]

[0258] Preparation of phosphorus-containing reagents

[0259] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (42 mmol, 3.12 g, 4.2 eq) was added dropwise, and the mixture was filtered to obtain compound 5, which was directly used in step a).

[0260] Step a).

[0261] L-homoserine butyl ester hydrochloride (10 mmol, 2.11 g, 1 eq) was placed in a sealed tube, vented, and chlorobenzene (20 mL), the prepared compound 5 and NaI (1 mmol, 0.15 g, 0.1 eq) were added under N2 atmosphere, and heated at 120°C for 8 hours.

[0262] Step b).

[0263] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 81% and an ee value of 87%.

[0264] Embodiment 18

[0265]

[0266] Preparation of phosphorus-containing reagents

[0267] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, diethylamine (42 mmol, 3.12 g, 4.2 eq) was added dropwise, and the mixture was filtered to obtain compound 5, which was directly used in step a).

[0268] Step a).

[0269] L-homoserine butyl ester hydrochloride (10 mmol, 2.11 g, 1 eq) was placed in a sealed tube and ventilated. Chlorobenzene (20 mL), prepared compound 5 and I2 (1 mmol, 0.25 g, 0.1 eq) were added under N2 atmosphere and heated at 120°C for 8 hours.

[0270] Step b).

[0271] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-glufosinate with a yield of 81% and an ee value of 90%.

[0272] Embodiment 19

[0273]

[0274] Preparation of phosphorus-containing reagents

[0275] Methylphosphine dichloride (11 mmol, 1.29 g, 1.1 eq) was dissolved in chlorobenzene (10 mL) under ice bath, aniline (42 mmol, 3.91 g, 4.2 eq) was added dropwise, and the mixture was filtered to obtain compound 4, which was directly used in step a).

[0276] Step a).

[0277] L-homoserine butyl ester hydrochloride (10 mmol, 2.11 g, 1 eq) was placed in a sealed tube, vented, and chlorobenzene (20 mL), the prepared compound 4 and NaI (1 mmol, 0.15 g, 0.1 eq) were added under N2 atmosphere, and heated at 120°C for 8 hours.

[0278] Step b).

[0279] The reaction mixture obtained in step a) was filtered, the filtrate was spin-dried, 30% hydrochloric acid (7 g) was added, and the temperature was raised to 100° C. for hydrolysis overnight to obtain L-phosphinothionimmonium with a yield of 78% and an ee value of 88%.

[0280] In addition to those described herein, various modifications of the present invention will be apparent to those skilled in the art based on the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. Each reference cited in this application (including all patents, patent applications, journal articles, books and any other disclosures) is incorporated herein by reference in its entirety.

Claims

1. A method for preparing glufosinate-ammonium or its salts, enantiomers or mixtures of enantiomers in all proportions of formula (I), characterized in that: The method comprises the following steps: a) reacting a compound of formula (II) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios with a phosphorus-containing reagent (preferably a compound of formula (III), formula (III)-1, formula (III)-2, formula (III)-3 and / or formula (III)-4), b) reacting in the presence of water and an acid or base to obtain glufosinate (I) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios, regardless of whether the intermediate is isolated or not; When PG is an amino protecting group, the step of removing the amino protecting group may also be included; in: X is -OR c 、-SR c Or -SeR c ; Y is -OH, -OR1, -NH2, -NHR2 or -N(R2)(R3); PG is hydrogen or an amino protecting group, and the amino protecting group is preferably -C(=O)R4, -C(=O)OR4 or -S(=O)2R4; R1, R2 and R3 are each independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl or -Si(R5)(R6)(R7); R4 is selected from C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; R5, R6 and R7 are each independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14-membered heteroaryl or 3-10-membered heterocyclic group; R, R" and R"' are each independently selected from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b 、-Si(R5)(R6)(R7), R' is independently selected at each occurrence from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b and -Si(R5)(R6)(R7); R a and R b Each occurrence is independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclic group; or when R a and R b When connected to the same nitrogen atom, R a , R b Optionally, together with the nitrogen atom, they form a 3-10 membered heterocyclic ring; R c Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R d 、-S(=O)R d ,-PH(=O)R d and -P(OH)(=O)R d ; Hal is independently at each occurrence a halogen selected from fluorine, chlorine, bromine and iodine; R d Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; The above alkylene, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl and heterocyclic groups are each optionally substituted by one or more substituents independently selected from the following: halogen, -OH, =O, -O-(C1-C6 alkyl), -C(=O)-(C1-C6 alkyl), -C(=O)OH, -C(=O)O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; n is an integer selected from 1 to 6, preferably 1, 2 or 3; Chiral carbon atoms are marked with *.

2. A method for preparing a compound of formula (I)-1 or a salt thereof, an enantiomer or a mixture of enantiomers in all proportions, characterized in that: The method comprises the following steps: a) reacting a compound of formula (II) or a salt thereof, an enantiomer or a mixture of enantiomers in all ratios with a phosphorus-containing reagent (preferably a compound of formula (III), formula (III)-1, formula (III)-2, formula (III)-3 and / or formula (III)-4), b-1) reacting in the presence of R8OH to obtain a compound of formula (I)-1 or a salt thereof, an enantiomer or a mixture of enantiomers in all proportions, regardless of whether the intermediate is isolated or not; When PG is an amino protecting group, the step of removing the amino protecting group may also be included; in: X is -OR c 、-SR c Or -SeR c ; Y is -OH, -OR1, -NH2, -NHR2 or -N(R2)(R3); PG is hydrogen or an amino protecting group, and the amino protecting group is preferably -C(=O)R4, -C(=O)OR4 or -S(=O)2R4; R1, R2 and R3 are each independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclyl or -Si(R5)(R6)(R7); R4 is selected from C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; R5, R6 and R7 are each independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14-membered heteroaryl or 3-10-membered heterocyclic group; R, R" and R"' are each independently selected from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b 、-Si(R5)(R6)(R7), R' is independently selected at each occurrence from H, halogen, -CN, -NO2, C 1-6 Alkyl, C 2-6 Alkenyl, C 2-6 Alkynyl, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-14 membered heteroaryl, C 6-12 Aralkyl, -C(=O)R a 、-OC(=O)R a 、-C(=O)OR a 、-OR a 、-SR a 、-S(=O)R a 、-OS(=O)R a 、-S(=O)2R a 、-OS(=O)2R a 、-S(=O)2NR a R b 、-NR a R b 、-C(=O)NR a R b 、-NR a -C(=O)R b 、-NR a -C(=O)OR b 、-NR a -S(=O)2-R b 、-NR a -C(=O)-NR a R b , -C 1-6 Alkylene-OR a , -C 1-6 Alkylene-NR a R b and -Si(R5)(R6)(R7); R a and R b Each occurrence is independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclic group; or when R a and R b When connected to the same nitrogen atom, R a , R b Optionally, together with the nitrogen atom, they form a 3-10 membered heterocyclic ring; R c Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R d 、-S(=O)R d ,-PH(=O)R d and -P(OH)(=O)R d ; Hal is independently at each occurrence a halogen selected from fluorine, chlorine, bromine and iodine; R d Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; R8 is H, C1-C6 alkyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl or 3-10 membered heterocyclyl; preferably, R8 is H or C1-C6 alkyl; more preferably, R8 is H, methyl or ethyl; The above alkylene, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl and heterocyclic groups are each optionally substituted by one or more substituents independently selected from the following: halogen, -OH, =O, -O-(C1-C6 alkyl), -C(=O)-(C1-C6 alkyl), -C(=O)OH, -C(=O)O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; n is an integer selected from 1 to 6, preferably 1, 2 or 3; Chiral carbon atoms are marked with *.

3. The method according to claim 1 or 2, wherein the compound of formula (II) in step a) is enantiomerically pure, and the obtained compound of formula (I) glufosinate-ammonium or its salt or formula (I)-1 or its salt is also enantiomerically pure.

4. The method according to claim 1 or 2, wherein the enantiomeric ratio of the compound of formula (I) glufosinate or its salt or the compound of formula (I)-1 or its salt is 50.5:49.5 to 99.5:0.5 (L):(D)-enantiomer or (D):(L)-enantiomer.

5. The method according to any one of claims 1 to 4, wherein in step a) R is not added e OH; R e Each occurrence is independently selected from hydrogen, Hal, -Hal-(=O), -Hal-(=O)2, -Hal-(=O)3, -N(=O), -NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, -C(=O)R f 、-S(=O)R f 、-S(=O)2R f ,-PH(=O)R f and -P(OH)(=O)R f ; R f Each occurrence is independently selected from hydrogen, hydroxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C 3-10 Cycloalkyl, C 6-10 Aryl, C 6-12 Aralkyl, 5-14 membered heteroaryl and 3-10 membered heterocyclyl; Preferably, no H2O is added in step a).

6. The method according to any one of claims 1 to 5, wherein R c are independently selected at each occurrence from hydrogen, C1-C6 alkyl, -C(=O)R d and -PH(=O)R d , and R d is C1-C6 alkyl or C 6-10 Aryl; Preferably, X is -OH or -OAc; More preferably, X is -OH, that is, the compound of formula (II) is a compound of formula (II)-1:

7. The method according to any one of claims 1 to 6, wherein R1, R2 and R3 are each independently C1-C6 alkyl, C 6-10 Aryl or C 6-12 Aralkyl; Preferably, R1, R2 and R3 are each independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl, phenyl, benzyl, phenethyl, phenylpropyl, methylphenyl, ethylphenyl, propylphenyl or naphthyl.

8. The method of any one of claims 1-7, wherein Y is -NHCH2CH2CH2CH3, -N(CH3)2, -OCH3, -OCH2CH3, -OCH2CH2CH3, -OCH(CH3)2, -OCH2CH2CH2CH3, -OCH2CH(CH3)2, or -OBn.

9. The method according to any one of claims 1 to 8, wherein Y is -OR1, and R1 is preferably methyl, ethyl, n-propyl, isopropyl or n-butyl.

10. The method according to any one of claims 1 to 9, wherein the PG is hydrogen, -C(=O)CH3, -C(=O)Ph, -C(=O)OC2H5, -C(=O)OC(CH3)3 or Preferably, PG is hydrogen.

11. The method according to any one of claims 1 to 10, wherein said R and R' are each independently H, halogen, -OR a or -NR a R b , R a and R b Each occurrence is independently hydrogen, C1-C6 alkyl, C 3-10 Cycloalkyl, C 6-10 Aryl or C 6-12 Aralkyl; preferably, R a and R bis independently hydrogen or C1-C6 alkyl at each occurrence; Preferably, R and R' are each independently H, Cl, -OH, -OEt, -NH2 or -N(CH3)2; Preferably, R and R' are not both -OR a .

12. The method according to any one of claims 1 to 11, wherein the compound of formula (III) is Among them, Hal 1 and Hal 2 are each independently a halogen selected from fluorine, chlorine, bromine and iodine; and The remaining groups are as defined in any one of the preceding claims; Preferably, the compound of formula (III) is selected from: More preferably, the compound of formula (III) is selected from:

13. The method according to any one of claims 1 to 12, wherein the molar ratio of the compound of formula (II) to the phosphorus-containing reagent is less than 2:1, preferably less than 1.5:1, more preferably not higher than 1:

1.

14. The method according to any one of claims 1 to 13, wherein in the step a), the reaction temperature is -50 to 200°C, preferably -20 to 150°C, -20 to 140°C, -20 to 100°C, -20 to 50°C, -20 to 30°C, 20 to 100°C or 0 to 100°C.

15. The method according to any one of claims 1 to 14, wherein in step a), the reaction is first carried out at a first reaction temperature, and then the temperature is raised to a second reaction temperature to continue the reaction; in, The first reaction temperature is -50 to 100°C, preferably -20 to 30°C; the second reaction temperature is 30-200°C, preferably 90-150°C.

16. The method according to claim 15, when at the second reaction temperature, the reaction is carried out in the presence of a catalyst, the catalyst is preferably an organic iodide, an inorganic iodide, an organic bromide, an inorganic bromide, an organic chloride or an inorganic chloride; preferably iodine, TBAI, TMSI, NCS, sodium iodide, potassium iodide or AlCl3; Preferably, the molar ratio of the catalyst to the compound of formula (III) is (0.01-1):1, preferably (0.01-0.5):

1.

17. The method according to any one of claims 1 to 16, wherein no halogenated acid (such as hydrogen chloride gas) is added in step a); Preferably, step a) is carried out in the presence of a base, which is an inorganic base or an organic base; The inorganic base is preferably ammonia, an alkali metal oxide, an alkaline earth metal oxide, an alkali metal carbonate, an alkaline earth metal carbonate, an alkali metal bicarbonate or an alkaline earth metal bicarbonate; for example, ammonia, potassium bicarbonate, sodium bicarbonate, lithium carbonate, potassium carbonate, sodium carbonate, cesium carbonate, calcium carbonate, magnesium carbonate, calcium oxide and magnesium oxide; The organic base is preferably diethylamine, triethylamine, N,N-dimethylaniline, piperidine or pyridine, wherein the triethylamine, N,N-dimethylaniline, piperidine and pyridine are optionally substituted by 1 to 3 substituents selected from halogen, -OH, -O-(C1-C6 alkyl), -NH2, -NO2, -CN, C1-C6 alkyl, C 3-10 Cycloalkyl and C 6-10 Aryl.

18. The method according to any one of claims 1 to 17, wherein in step a), the molar ratio of the base to the compound of formula (III) is (1-10):1, for example (1-5):

1.

19. The method according to any one of claims 1 to 18, wherein step a) is carried out under solvent-free conditions or in an inert solvent; Preferably, the inert solvent is selected from any one or more of benzene solvents, amide solvents, nitrile solvents, hydrocarbon solvents, halogenated hydrocarbon solvents, sulfone or sulfoxide solvents, ether solvents or ester solvents; Preferably, the inert solvent is selected from any one or more of benzene solvents, amide solvents, halogenated hydrocarbon solvents, ether solvents or ester solvents; More preferably, the inert solvent is selected from any one or more of chlorobenzene, toluene, xylene, trimethylbenzene, acetonitrile, 1,4-dioxane, 1,2-dichloroethane, dimethyl sulfoxide, N-methylpyrrolidone, N,N-dimethylformamide, petroleum ether, n-heptane, tetrahydrofuran, methyltetrahydrofuran, benzene, toluene, ethyl acetate, and butyl acetate.

20. The method according to any one of claims 1 to 19, wherein in step b), an inorganic acid or an organic acid is added.

21. The method according to claim 20, wherein the inorganic acid is hydrochloric acid or sulfuric acid.

22. The method according to any one of claims 1 to 19, wherein in step b), the base is an inorganic base or an organic base.

23. The process of claim 22, wherein the base is an alkali metal hydroxide, an alkaline earth metal hydroxide, an alkali metal carbonate, an alkaline earth metal carbonate, an alkali metal bicarbonate or an alkaline earth metal bicarbonate.

24. The method of claim 23, wherein the base is NaOH, KOH or Ba(OH)2.

25. The method according to any one of claims 1-24, wherein in step b), the reaction temperature is 20-150°C.

26. The method according to claim 2, wherein in step b-1), the reaction temperature is 0°C to 100°C, for example, at a temperature of 0°C to 80°C, 0°C to 60°C, 0°C to 40°C, 0°C to 30°C, 0°C to 20°C, 30°C to 80°C or 30°C to 60°C.